Laurus Labs
Laurus is a research-driven CDMO committed to improving the quality of life for millions of patients worldwide. With deep expertise in the development, manufacturing, characterization, and particle size control of highly potent compounds, Laurus supports the unique complexity of targeted protein degradation programs. Our teams have successfully addressed the challenges associated with PROTACs and molecular glue degraders, delivering robust, scalable solutions from early development through late clinical and commercial phases—helping customers advance innovative therapies with confidence.
